This document provides a short summary of this study for a general audience. You can
find more information in the scientific summary of the study. A link to the summary is
provided at the end of this document.
Study names
Short Title: A study to assess how well two different doses of fluticasone furoate nasal
spray work and how safe they are in Chinese children with allergic rhinitis.
Full Scientific Title: A Randomized, Doubled-Blind, Placebo-Controlled, Multicentre
Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of
Fluticasone Furoate Nasal Spray 55 µg and 110 µg for 4 Weeks in Chinese Paediatric
Subjects Ages 2 to 12 years with Allergic Rhinitis.
Study Number: 201492
Who sponsored this study?
GlaxoSmithKline (GSK)
GSK Clinical Support Help Desk
Website: www.clinicalsupporthd.gsk.com
Email: GSKClinicalSupportHD@gsk.com
General information about the study
When and where was this study done?
The study started in September 2015 and ended in October 2017. All study sites were
in China.
What were the reasons for conducting this study?
An allergic reaction is the body’s response to foreign substances called allergens.
Allergic rhinitis is a type of allergic reaction that affects the nose. It is caused when
people breathe in substances like pollen, dust, mould or flakes of skin from certain
animals. Allergic rhinitis causes symptoms, such as:
• Runny, stuffy nose.
• Sneezing.
• Itchy nose and eyes.
• Red, burning and watery eyes.
© 2018 GSK. All rights reserved. Unauthorised copying of this information is prohibited.